Effect of vitamin E and Probucol on dietary cholesterol-induced atherosclerosis in rabbits

Free Radical Biology and Medicine

Volumn 24, Issue 2, 1998, Pages 226-233

  Özer, Nesrin K ^a   Şirikçi, Önder ^a   Taha, Suzan ^a   Şan, Tangül ^a   Moser, Ulrich ^a   Azzi, Angelo ^b  

^a MARMARA UNIVERSITY   (Turkey)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Tocopherol; Atherosclerosis; Free radicals; Probucol; Protein kinase C; Rabbit aortic smooth muscle cells; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; PROBUCOL; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL INTAKE; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VITAMIN INTAKE;

ANIMALS; ANTICHOLESTEREMIC AGENTS; AORTA; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTEROL, DIETARY; ENDOTHELIUM, VASCULAR; MALE; MICROSCOPY, ELECTRON, SCANNING; MUSCLE, SMOOTH, VASCULAR; PROBUCOL; PROTEIN KINASE C; RABBITS; VITAMIN E;

ANIMALIA; HUMAN ECHOVIRUS 1; ORYCTOLAGUS CUNICULUS;

EID: 0037558331     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00136-6     Document Type: Article

References (65)

1. Raines E. W., Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br. Heart. J. 69:1993;S30-S37.
2. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
3. Ross R., Agius L. The process of atherogenesis - Cellular and molecular interaction: From experimental animal models to humans. Diabetologia. 35:(Suppl. 2):1992;S34-S40.
4. Steinberg D. Clinical trials of antioxidants in atherosclerosis: Are we doing the right thing. Lancet. 346:1995;36-38.
5. Steinberg D. Role of oxidized LDL and antioxidants in atherosclerosis. Adv. Exp. Med. Biol. 369:1995;39-48.
6. Benz D. J., Mol M., Ezaki M., Mori Ito N., Zelan I., Miyanohara A., Friedmann T., Parthasarathy S., Steinberg D., Witztum J. L. Enhanced levels of lipoperoxides in low density lipoprotein incubated with murine fibroblast expressing high levels of human 15-lipoxygenase. J. Biol. Chem. 270:1995;5191-5197.
7. Parthasarathy S., Steinberg D., Witztum J. L. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43:1992;219-225.
8. Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1991;1785-1792.
9. Hennekens C.H., Gaziano J. M. Antioxidants and heart disease: Epidemiology and clinical evidence. Clin. Cardiol. 16:1993;10-13.
10. Rimm E. B., Stampfer M. J., Ascherio A., Giovannucci E., Colditz G. A., Willett W. C. Vitamin E consumption and the risk of coronary heart disease in men (see comments). N. Engl. J. Med. 328:1993;1450-1456.
11. Stampfer M. J., Hennekens C. H., Manson J. E., Colditz G. A., Rosner B., Willett W. C. Vitamin E consumption and the risk of coronary disease in women (see comments). N. Engl. J. Med. 328:1993;1444-1449.
12. Shum Tim D., Tchervenkov C. I., Chiu R. C. Oral vitamin E prophylaxis in the protection of newborn myocardium from global ischemia. Surgery. 112:1992;441-449.
13. Gey K. F., Puska P., Jordan P., Moser U. K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53:1991;326S-334S.
14. Gey K. F. The antioxidant hypothesis of cardiovascular disease: Epidemiology and mechanisms. Biochem. Soc. Trans. 18:1990;1041-1045.
15. Gey K. F., Puska P. Plasma vitamins E and A inversely correlated to mortality from ischemic heart disease in cross-cultural epidemiology. Ann. NY Acad. Sci. 570:1989;268-282.
16. Stephens N. G., Parsons A., Schofield P. M., Kelly F., Cheeseman K., Mitchinson M. J., Brown M. I. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 347:1996;781-786.
17. Özer N. K., Boscoboinik D., Azzi A. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem. Mol. Biol. Int. 35:1995;117-124.
18. Azzi A., Boscoboinik D., Chatelain E., Özer N. K., Stäuble B. d-Alpha-tocopherol control of cell proliferation. Mol. Aspects Med. 14:1993;265-271.
19. Özer N. K., Palozza P., Boscoboinik D., Azzi A. d-Alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. FEBS Lett. 322:1993;307-310.
20. Şirikçi Ö., Özer N. K., Azzi A. Dietary cholesterol-induced changes of protein kinase C and the effect of vitamin E in rabbit aorta smooth muscle cells. Atherosclerosis. 126:1996;253-263.
21. Schneider J. E., Berk B. C., Gravanis M. B., Santoian E. C., Cipolla G. D., Tarazona N., Lassegue B., King S. B. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury. A possible role for antioxidants in restenosis. Circulation. 88:1993;628-637.
22. Kleinveld H. A., Demacker P. N. M., Stalenhoef A. F. H. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. 14:1994;1386-1391.
23. Daugherty A., Zweifel B. S., Schonfeld G. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Br. J. Pharmacol. 98:1989;612-618.
24. Nagano Y., Kita T., Yokode M., Ishii K., Kume N., Otani H., Arai H., Kawai C. Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 9:1989;453-461.
25. Stein Y., Stein O., Delplanque B., Fesmire J. D., Lee D. M., Alaupovic P. Lack of effect of probucol on atheroma formation in cholesterol-fed rabbits kept at comparable plasma cholesterol levels. Atherosclerosis. 75:1989;145-155.
26. Ferns G. A., Forster L., Stewart Lee A., Konneh M., Nourooz Zadeh J., Anggard E. E. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc. Natl. Acad. Sci. USA. 89:1992;11312-11316.
27. Carew T. E., Schwenke D. C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84:1987;7725-7729.
28. Chang M. Y., Sasahara M., Chait A., Raines E. W., Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol 2. Cellular composition and proliferation. Arterioscler. Thromb. Vasc. Biol. 15:1995;1631-1640.
29. Schwartz C. J., Valente A. J., Sprague E. A. A modern view of atherogenesis. Am. J. Cardiol. 71:1993;9B-14B.
30. Harris W. S. The prevention of atherosclerosis with antioxidants. Clin. Cardiol. 15:1992;636-640.
31. Kok F. J., van Poppe G., Melse J., Verheul E., Schouten E. G., Kruyssen D. H., Hofman A. Do antioxidants and polyunsaturated fatty acids have a combined association with coronary atherosclerosis? Atherosclerosis. 86:1991;85-90.
32. van Poppel G., Kardinaal A., Princen H., Kok F. J. Antioxidants and coronary heart disease. Ann. Med. 26:1994;429-434.
33. Bocan T. M., Mueller S. B., Mazur M. J., Uhlendorf P. D., Brown E. Q., Kieft K. A. The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation. Atherosclerosis. 102:1993;9-22.
34. Mantha S. V., Prasad M., Kalra J., Prasad K. Antioxidant enzymes in hypercholesterolemia and effects of vitamin E in rabbits. Atherosclerosis. 101:1993;135-144.
35. Konneh M. K., Rutherford C., Li S. R., Ängård E. E., Ferns G. A. A. Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat. Atherosclerosis. 113:1995;29-39.
36. Aliev G., Mironov A., Cirillo R., Mironov A. Jr., Gorelova E., Prosdocimi M. Evidence for the presence of early vascular lesions in newborn Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis. 101:1993;17-24.
37. Kolpakov V., Di Sciullo A., Nasuti M., Di Nardo P., Mironov A., Poggi A. Reduced smooth muscle cell regeneration in Yoshida (YOS) spontaneously hypercholesterolemic rats. Atherosclerosis. 111:1994;227-236.
38. Watson N. L. Staining of tissue sections for electron microscopy with heavy metals. J Biophys. Biochem. Cytol. 4:1958;475.
39. Porreca E., Ciccarelli R., Di Febbo C., Cuccurullo F. Protein kinase C pathway and proliferative responses of aged and young rat vascular smooth muscle cells. Atherosclerosis. 104:1993;137-145.
40. Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. I. Protein measurements with the Folin phenol reagent. J. Biol. Chem. 193:1951;265.
41. Nierenberg D. W., Nann S. L. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am. J. Clin. Nutr. 56:1992;417-426.
42. Godfried S. L., Combs G. F. Jr., Saroka J. M., Dillingham L. A. Potentiation of atherosclerotic lesions in rabbits by a high dietary level of vitamin E. Br. J. Nutr. 61:1989;607-617.
43. Wilson R. B., Middleton C. C., Sun G. Y. Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits. J. Nutr. 108:1978;1858-1867.
44. Bitman J., Weyant J., Wood D. L., Wrenn T. R. Vitamin E, cholesterol, and lipids during atherogenesis in rabbits. Lipids. 11:1976;449-461.
45. Bjorkhem J., Henriksson Freyschuss A., Breuer O., Diczfalusy U., Berglund L., Henriksson P. The antioxidant butylated hydroxytoluene protects against atherosclerosis. Arterioscler. Thromb. 11:1991;15-22.
46. Morel D. W., De la Llera-Moya M., Friday K. E. Treatment of cholesterol-fed rabbits with dietary vitamins E and C inhibits lipoprotein oxidation but not development of atherosclerosis. J. Nutr. 124:1994;2123-2130.
47. Esterbauer H., Waeg G., Puhl H., Dieber Rotheneder M., Tatzber F. Inhibition of LDL oxidation by antioxidants. EXS. 62:1992;145-157.
48. Gey K. F., Moser U. K., Jordan P., Stahelin H. B., Eichholzer M., Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: An epidemiological update with special attention to carotene and vitamin C. Am. J. Clin. Nutr. 57:1993;787S-797S.
49. Stahelin H. B., Eichholzer M., Gey K. F. Nutritional factors correlating with cardiovascular disease: Results of the Basel Study. Bibl. Nutr. Diet. 49:1992;24-35.
50. Kita T., Nagano Y., Yokode M., Ishii K., Kume N., Ooshima A., Yoshida H., Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA. 84:1987;5928-5931.
51. Boscoboinik D., Szewczyk A., Azzi A. Alpha-tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys. 286:1991;264-269.
52. Azzi A., Boscoboinik D., Hensey C. The protein kinase C family. Eur. J. Biochem. 208:1992;547-557.
53. Boscoboinik D., Szewczyk A., Hensey C., Azzi A. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. J. Biol. Chem. 266:1991;6188-6194.
54. Azzi A., Boscoboinik D., Marilley D., Özer N. K., Stäuble B., Tasinato A. Vitamin E: A sensor and an information transducer of the cell oxidation state. Am. J. Clin. Nutr. Suppl. 62:1995;1337S-1346S.
55. Tasinato A., Boscoboinik D., Bartoli G. M., Maroni P., Azzi A. d-α-Tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties. Proc. Natl. Acad. Sci. USA. 92:1995;12190-12194.
56. Cohn W., Kuhn H. The role of the low density lipoprotein receptor for α-tocopherol delivery to tissues. Ann. NY Acad. Sci. 570:1989;61-71.
57. Hsiang Y., White R. A., Kopchok G. E., Rosenbaum D., Guthrie C., Kao J., Zhen E. Z., Peng S. K., Fragoso M. Stenosis following laser thermal angioplasty - A blinded controlled randomized study between aspirin against Probucol. J. Surg. Res. 50:1991;252-258.
58. Freyschuss A., Stiko Rahm A., Swedenborg J., Henriksson P., Bjorkhem I., Berglund L., Nilsson J. Antioxidant treatment inhibits the development of intimal thickening after balloon injury of the aorta in hypercholesterolemic rabbits. J. Clin. Invest. 91:1993;1282-1288.
59. Lafont A. M., Chai Y. C., Cornhill J. F., Whitlow P. L., Howe P. H., Chisolm G. M. Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis. J. Clin. Invest. 95:1995;1018-1025.
60. Elinder L. S., Hådell K., Johansson J., Molgaard J., Holme I., Olsson A. G., Walldius G. Probucol treatment decreases serum concentrations of diet-derived antioxidants. Arterioscler. Thromb. Vasc. Biol. 15:1995;1057-1063.
61. Castellot J. J. Jr., Pukac L. A., Caleb B. L., Wright T. C. Jr., Karnovsky M. J. Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells (published erratum appears in J. Cell Biol. 1990 Mar; 110:863). J. Cell. Biol. 109:1989;3147-3155.
62. Matsumoto H., Sasaki Y. Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 158:1989;105-109.
63. Chatelain E., Boscoboinik D. O., Bartoli G. M., Kagan V. E., Gey F. K., Packer L., Azzi A. Inhibition of smooth muscle cell proliferation and protein kinase C activity by tocopherols and tocotrienols. Biochim. Biophys. Acta. 1176:1993;83-89.
64. Newby A. C., Lim K., Evans M. A., Brindle N. P., Booth R. F. Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C. Br. J. Pharmacol. 114:1995;1652-1656.
65. Boscoboinik D., Özer N. K., Moser U., Azzi A. Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit vascular smooth muscle cell proliferation by a nonantioxidant mechanism. Arch. Biochem. Biophys. 318:1995;241-246.